Journal ArticleDOI
QRS duration and mortality in patients with congestive heart failure
TLDR
QRS prolongation is an independent predictor of both increased total mortality and sudden death in patients with heart failure and age, type of cardiomyopathy, and drug treatment group were not predictive of mortality.About:
This article is published in American Heart Journal.The article was published on 2002-06-01. It has received 395 citations till now. The article focuses on the topics: Sudden death & QRS complex.read more
Citations
More filters
Journal ArticleDOI
Sleep Apnea and Cardiovascular Disease An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
Virend K. Somers,David P. White,Raouf S. Amin,William T. Abraham,Fernando Ferreira Costa,Antonio Culebras,Stephen R. Daniels,John S. Floras,Carl E. Hunt,Lyle J. Olson,Thomas G. Pickering,Richard O. Russell,Mary Woo,Terry Young +13 more
TL;DR: This first American Heart Association/American College of Cardiology Scientific Statement on Sleep Apnea and Cardiovascular Disease seeks to highlight concepts and evidence important to understanding the interactions between sleep apnea and cardiovascular disease, with particular attention to more recent advances in patient-oriented research.
Journal ArticleDOI
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Sana M. Al-Khatib,William G. Stevenson,Michael J. Ackerman,William J. Bryant,David J. Callans,Anne B. Curtis,Barbara J. Deal,Timm Dickfeld,Michael E. Field,Gregg C. Fonarow,Anne M. Gillis,Christopher B. Granger,Stephen C. Hammill,Mark A. Hlatky,Jose A. Joglar,G. Neal Kay,Daniel D. Matlock,Robert J. Myerburg,Richard L. Page +18 more
TL;DR: The next chair and vice-chair will be announced at a special meeting of the American Academy of Anti-Accident and Accident Medicine (AACC) board of directors in New York later this month.
Journal ArticleDOI
Predictors of mortality and morbidity in patients with chronic heart failure
Stuart J. Pocock,Duolao Wang,Marc A. Pfeffer,Salim Yusuf,John J.V. McMurray,Karl Swedberg,Jan Östergren,Eric L. Michelson,Karen S. Pieper,Christopher B. Granger +9 more
TL;DR: In a large contemporary CHF population, including patients with preserved and decreased left ventricular systolic function, routine clinical variables can discriminate risk regardless of EF and diabetes was found to be a surprisingly strong independent predictor.
Journal ArticleDOI
Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients.
Maria Teresa La Rovere,Gian Domenico Pinna,Roberto Maestri,Andrea Mortara,Soccorso Capomolla,Oreste Febo,Roberto Ferrari,Mariella Franchini,Marco Gnemmi,Cristina Opasich,Pier Giorgio Riccardi,Egidio Traversi,Franco Cobelli +12 more
TL;DR: Reduced short-term LFP during controlled breathing is a powerful predictor of sudden death in patients with CHF that is independent of many other variables, and refine the identification of patients who may benefit from prophylactic implantation of a cardiac defibrillator.
Journal ArticleDOI
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Fred M. Kusumoto,Mark H. Schoenfeld,Coletta Barrett,James R. Edgerton,Kenneth A. Ellenbogen,Michael R. Gold,Nora Goldschlager,Robert M. Hamilton,Jose A. Joglar,Robert Kim,Richard T. Lee,Joseph E. Marine,Christopher J. McLeod,Keith R. Oken,Kristen K. Patton,Cara N. Pellegrini,Kimberly A. Selzman,Annemarie Thompson,Paul D. Varosy +18 more
TL;DR: The next generation of scientists and decision-makers will be shaped by the experiences of those who have gone before them and will help shape the future of medicine and science.
References
More filters
Journal ArticleDOI
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
Bertram Pitt,Faiez Zannad,Willem J. Remme,Robert J. Cody,Alain Castaigne,Alfonso Perez,Jolie Palensky,Janet Wittes +7 more
TL;DR: Blockade of aldosterone receptors by spironolactone, in addition to standard therapy, substantially reduces the risk of both morbidity and death among patients with severe heart failure.
Journal ArticleDOI
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
TL;DR: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
Journal ArticleDOI
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Bertram Pitt,Faiez Zannad,Willem J. Remme,Robert J. Cody,Alain Castaigne,Alfonso Perez,Jolie Palensky,Janet Wittes +7 more
Journal ArticleDOI
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Milton Packer,Michael R. Bristow,Jay N. Cohn,Wilson S. Colucci,Michael B. Fowler,Edward M. Gilbert,Neil H. Shusterman +6 more
TL;DR: Carvedilol reduces the risk or death as well as the risk of hospitalization for cardiovascular causes in patients with heart failure who are receiving treatment with digoxin, diuretics, and an angiotensin-converting-enzyme inhibitor.
Journal Article
The Effect of Carvedilol on Morbidity and Mortality in Patients With Chronic Heart Failure
Milton Packer,Michael R. Bristow,Jay N. Cohn,Wilson S. Colucci,Michael B. Fowler,Edward M. Gilbert,Neil H. Shusterman +6 more
TL;DR: In this paper, a double-blind, placebo-controlled, stratified program, in which patients were assigned to one of four treatment protocols on the basis of their exercise capacity, was presented.